Good reminder, thefamilyman. I'm going to start keeping a list of points like that (the lesser likelihood of Brilacidin developing antibiotic-resistance problems) which can be added to the stickie note with the DD summary as "additional data." If anyone has any other ideas about things to add, please post them and I'll add them to the list. That's supposed to be a collaborative document that we change periodically as news becomes available.

Here's the stickie if anyone wants to check to see what needs to be added:

http://investorshangout.com/post/view?id=3114595

If someone would care to write a quick few sentences or a paragraph summary of the financing that will carry us through for the next year (just that we do have it etc) I'll add that to the list. No need to be super careful about wording or anything, I'll edit/revise it for consistency of style before the next update to the DD stickie.